182 related articles for article (PubMed ID: 23931935)
1. Safety and efficacy of botulinum toxin in primary orthostatic tremor.
Bertram K; Sirisena D; Cowey M; Hill A; Williams DR
J Clin Neurosci; 2013 Nov; 20(11):1503-5. PubMed ID: 23931935
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
Van Der Walt A; Sung S; Spelman T; Marriott M; Kolbe S; Mitchell P; Evans A; Butzkueven H
Neurology; 2012 Jul; 79(1):92-9. PubMed ID: 22753445
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A for treating voice tremor.
Adler CH; Bansberg SF; Hentz JG; Ramig LO; Buder EH; Witt K; Edwards BW; Krein-Jones K; Caviness JN
Arch Neurol; 2004 Sep; 61(9):1416-20. PubMed ID: 15364688
[TBL] [Abstract][Full Text] [Related]
4. Blinded placebo crossover study of gabapentin in primary orthostatic tremor.
Rodrigues JP; Edwards DJ; Walters SE; Byrnes ML; Thickbroom GW; Stell R; Mastaglia FL
Mov Disord; 2006 Jul; 21(7):900-5. PubMed ID: 16532455
[TBL] [Abstract][Full Text] [Related]
5. [Orthostatic tremor inducing instability].
Manrique-Huarte R; Arcocha J; Pérez-Fernández N
Acta Otorrinolaringol Esp; 2012; 63(2):120-4. PubMed ID: 22154251
[TBL] [Abstract][Full Text] [Related]
6. AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled Trial.
Delgado MR; Tilton A; Russman B; Benavides O; Bonikowski M; Carranza J; Dabrowski E; Dursun N; Gormley M; Jozwiak M; Matthews D; Maciag-Tymecka I; Unlu E; Pham E; Tse A; Picaut P
Pediatrics; 2016 Feb; 137(2):e20152830. PubMed ID: 26812925
[TBL] [Abstract][Full Text] [Related]
7. Trial of Botulinum Toxin for Isolated or Essential Head Tremor.
Marques A; Pereira B; Simonetta-Moreau M; Castelnovo G; De Verdal M; Fluchère F; Laurencin C; Degos B; Tir M; Kreisler A; Blanchet-Fourcade G; Guehl D; Colin O; Poujois A; Sangla S; Tatu L; Derost P; Gayraud D; Tranchant C; Amarantini D; Devos D; Rascol O; Corvol JC; Durif F; Rieu I;
N Engl J Med; 2023 Nov; 389(19):1753-1765. PubMed ID: 37937777
[TBL] [Abstract][Full Text] [Related]
8. A dissociation between subjective and objective unsteadiness in primary orthostatic tremor.
Fung VS; Sauner D; Day BL
Brain; 2001 Feb; 124(Pt 2):322-30. PubMed ID: 11157559
[TBL] [Abstract][Full Text] [Related]
9. Primary orthostatic tremor is an exaggeration of a physiological response to instability.
Sharott A; Marsden J; Brown P
Mov Disord; 2003 Feb; 18(2):195-9. PubMed ID: 12539215
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor.
Jankovic J; Schwartz K; Clemence W; Aswad A; Mordaunt J
Mov Disord; 1996 May; 11(3):250-6. PubMed ID: 8723140
[TBL] [Abstract][Full Text] [Related]
11. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
[TBL] [Abstract][Full Text] [Related]
12. The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report.
Warrick P; Dromey C; Irish J; Durkin L
J Voice; 2000 Sep; 14(3):410-21. PubMed ID: 11021508
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
[TBL] [Abstract][Full Text] [Related]
14. Primary writing tremor: report of a case successfully treated with botulinum toxin A injections and discussion of underlying mechanism.
Singer C; Papapetropoulos S; Spielholz NI
Mov Disord; 2005 Oct; 20(10):1387-8. PubMed ID: 16007655
[TBL] [Abstract][Full Text] [Related]
15. Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series.
Papapetropoulos S; Singer C
Clin Neuropharmacol; 2006; 29(6):364-7. PubMed ID: 17095901
[TBL] [Abstract][Full Text] [Related]
16. Botulinum Toxin Type A Injections as Monotherapy for Upper Limb Essential Tremor Using Kinematics.
Samotus O; Kumar N; Rizek P; Jog M
Can J Neurol Sci; 2018 Jan; 45(1):11-22. PubMed ID: 29157315
[TBL] [Abstract][Full Text] [Related]
17. A new paradigm for the management of essential vocal tremor with botulinum toxin.
Gurey LE; Sinclair CF; Blitzer A
Laryngoscope; 2013 Oct; 123(10):2497-501. PubMed ID: 23553653
[TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: a randomised double-blind placebo-controlled trial.
Dowson C; Sahai A; Watkins J; Dasgupta P; Khan MS
Int J Clin Pract; 2011 Jun; 65(6):698-704. PubMed ID: 21564444
[TBL] [Abstract][Full Text] [Related]
19. Clinical and neurophysiologic spectrum of orthostatic tremor: case series of 26 subjects.
Piboolnurak P; Yu QP; Pullman SL
Mov Disord; 2005 Nov; 20(11):1455-61. PubMed ID: 16037915
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: a placebo controlled study.
Tassorelli C; De Icco R; Alfonsi E; Bartolo M; Serrao M; Avenali M; De Paoli I; Conte C; Pozzi NG; Bramanti P; Nappi G; Sandrini G
Parkinsonism Relat Disord; 2014 Nov; 20(11):1140-4. PubMed ID: 25175601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
